Market revenue in 2023 | USD 3,863.4 million |
Market revenue in 2030 | USD 6,990.5 million |
Growth rate | 8.8% (CAGR from 2023 to 2030) |
Largest segment | Alzheimer’s disease dementia |
Fastest growing segment | Lewy Body Dementia |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Alzheimer’s Disease Dementia, Vascular Dementia, Lewy Body Dementia, Frontotemporal Dementia (FTD), Parkinson Disease Dementia, Other Indications |
Key market players worldwide | Eisai Co Ltd, Eli Lilly and Co, Novartis AG ADR, Daiichi Sankyo Co Ltd, AbbVie Inc, H. Lundbeck AS Class A, Biogen Inc, Cipla Ltd DR, Sun Pharmaceutical Industries, Viatris Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to dementia treatment market will help companies and investors design strategic landscapes.
Alzheimer’s disease dementia was the largest segment with a revenue share of 60.14% in 2023. Horizon Databook has segmented the Asia Pacific dementia treatment market based on alzheimer’s disease dementia, vascular dementia, lewy body dementia, frontotemporal dementia (ftd), parkinson disease dementia, other indications covering the revenue growth of each sub-segment from 2018 to 2030.
Asia Pacific dementia treatment market is expected to register the fastest CAGR of 9.5% in the forecast period. The presence of a large target population, high unmet clinical needs, and developing healthcare is anticipated to provide high growth potential for the regional market.
It is expected that more than 75% of Alzheimer’s disease and related dementias to occur in low- and middle-income countries by 2050. Developing countries, such as China and India, have a large patient base with high unmet medical needs that create market opportunities for key players in the region.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific dementia treatment market, including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific dementia treatment market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account